Relief Therapeutics Holding AG (RLFTF)

[threebabiesbusy]

BRIEF-Relief Therapeutics And NeuroRx Announce FDA's Accelerated Designation Of RLF-100
1 MIN READ

June 24 (Reuters) - RELIEF THERAPEUTICS HOLDING SA:

* NEURORX AND RELIEF THERAPEUTICS ANNOUNCE FDA’S ACCELERATED DESIGNATION OF RLF-100 (AVIPTADIL) FOR THE TREATMENT OF RESPIRATORY DISTRESS IN COVID-19

* AT THE REQUEST OF THE FDA, NEURORX IS SUBMITTING AN EXPANDED ACCESS POLICY ALLOWING DOCTORS TO REQUEST RLF-100 FOR PATIENTS MEETING THIS CRITERION

* RLF-100 IS UNDERGOING PHASE 2/3 CLINICAL TRIALS

* RECRUITING PATIENTS WITH CRITICAL COVID-19 AND RESPIRATORY FAILURE Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Our Standards:The Thomson Reuters Trust Principles.

https://www.reuters.com/article/brief-relief-therapeutics-and-neurorx-an/brief-relief-therapeutics-and-neurorx-announce-fdas-accelerated-designation-of-rlf-100-idUSFWN2E10VC